These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30291815)

  • 1. The cytopathologist's expanding role in the 2018 updated molecular testing guidelines for lung cancer.
    Bellevicine C; Troncone G
    Cancer Cytopathol; 2018 Sep; 126(9):753-755. PubMed ID: 30291815
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
    Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
    Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building diagnoses with four layers: WHO 2016 classification of CNS tumors.
    Bielle F
    Rev Neurol (Paris); 2016; 172(4-5):253-5. PubMed ID: 27210026
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytology nomenclature and 2015 World Health Organization classification of lung cancer.
    Zakowski MF
    Cancer Cytopathol; 2016 Feb; 124(2):81-8. PubMed ID: 26461981
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of Infectious Diseases in the Lower Respiratory Tract: A Cytopathologist's Perspective.
    Baldassarri RJ; Kumar D; Baldassarri S; Cai G
    Arch Pathol Lab Med; 2019 Jun; 143(6):683-694. PubMed ID: 30203986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Papanicolaou Society of Cytopathology classification for pulmonary specimens: an overview.
    Layfield LJ
    Cytopathology; 2016 Jun; 27(3):149-52. PubMed ID: 27221749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.
    VanderLaan PA; Chen Y; DiStasio M; Rangachari D; Costa DB; Heher YK
    Clin Lung Cancer; 2018 Sep; 19(5):e589-e590. PubMed ID: 29798809
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review.
    Pitman MB; Layfield LJ
    Cancer Cytopathol; 2014 Jun; 122(6):399-411. PubMed ID: 24777782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations.
    Murugan P; Stevenson ME; Hassell LA
    Arch Pathol Lab Med; 2014 Jan; 138(1):105-9. PubMed ID: 24377817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to do it: how to get the most out of cerebrospinal fluid cytology.
    Milburn-McNulty P; Michael B; Moxham N; Fletcher N; Crooks D
    Pract Neurol; 2012 Aug; 12(4):241-3. PubMed ID: 22869767
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of cytopathologist's review of Pap tests screened as negative for intraepithelial lesion or malignancy that are positive for high-risk human papillomavirus.
    Walavalkar V; Fischer AH; Owens CL
    J Am Soc Cytopathol; 2015; 4(4):190-194. PubMed ID: 31051753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice guidelines and proficiency testing for molecular assays.
    Bellissimo DB;
    Transfusion; 2007 Jul; 47(1 Suppl):79S-84S. PubMed ID: 17593292
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.
    Volmar KE; Idowu MO; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2015 Sep; 139(9):1115-24. PubMed ID: 26317453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary pulmonary non-small cell carcinomas: the College of American Pathologists Interlaboratory Comparison Program confirms a significant trend toward subcategorization based upon fine-needle aspiration cytomorphology alone.
    Yildiz-Aktas IZ; Sturgis CD; Barkan GA; Souers RJ; Fraig MM; Laucirica R; Khalbuss WE; Moriarty AT
    Arch Pathol Lab Med; 2014 Jan; 138(1):65-70. PubMed ID: 24377813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standards for the diagnosis and treatment of primary lung cancer (2015 version) in China].
    Zhi X; Shi Y; Yu J
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):67-78. PubMed ID: 25877323
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-invasive follicular neoplasm with papillary like nuclear features (NIFTP): If it ain't broke, don't fix it. The cytopathologist's dilemma.
    LiVolsi VA; Layfield L; Baloch ZW
    Diagn Cytopathol; 2017 Jun; 45(6):479-480. PubMed ID: 28419773
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of methodology for lung cancer evidence review and guideline development.
    McCrory DC; Colice GL; Lewis SZ; Alberts WM; Parker S
    Chest; 2003 Jan; 123(1 Suppl):3S-6S. PubMed ID: 12527561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexities of Variant Classification in Clinical Hereditary Cancer Genetic Testing.
    Mundt E; Nix P; Brown K; Bowles KR; Manley S
    J Clin Oncol; 2017 Dec; 35(34):3796-3799. PubMed ID: 28981386
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for Colorectal Cancer Testing: Evidence-Based Practice Recommendations.
    Zehnbauer B; Temple-Smolkin R; Monzon FA
    J Mol Diagn; 2017 Mar; 19(2):183-186. PubMed ID: 28190460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off the mark: Current lung cancer screening guidelines miss those most at risk.
    Printz C
    Cancer; 2015 Aug; 121(15):2477-8. PubMed ID: 26198788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.